The Challenge of Change - Managing Excipients Control
Colorcon
09-Mar-2011 - Sanofi Aventis has had a busy few days with media speculation about potential job cuts following just 24 hours after the firm extended its takeover offer for Genzyme.
09-Mar-2011 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Gentium, Endo Pharmaceuticals and American Peptide Company.
08-Mar-2011 - Thermo Fisher Scientific has launched a predictive assay that, it claims, can assess a drug candidate’s potential to cause liver damage earlier than traditional methods.
07-Mar-2011 - CSM GlobalPharma has announced plans to invest $65m in a manufacturing facility in Kigali, Rwanda in collaboration with the Rwandan Development Board (RDB).
07-Mar-2011 - Eisai has unveiled plans to cut around 100 jobs in Japan, 600 in the US and 200 in Europe by 2015 as Aricept and some of its key products start to face generic competition.
07-Mar-2011 - Charles River Laboratories (CRL) said it will distribute several Pfizer-developed R&D models, in a deal that continues the US CRO’s efforts to expand its lab animals business.
07-Mar-2011 - Efforts to detect fakes with handheld spectrometers appear to be having a positive impact on drug quality in Nigeria according to research by US think-tank the American Enterprise Institute (AEI).
03-Mar-2011 - Governments must close loopholes and increase oversight to prevent diversion of pharmaceutical formulations into illicit supply chains.
01-Mar-2011 - New research has questioned the widely accepted $1.3bn average cost of R&D per new drug, claiming that it is an overestimate and an obstacle to the development of better medicines.
01-Mar-2011 - Generic drugmaker SOHM has expanded its manufacturing capacity for “lifestyle” diseases to meet growing Indian demand.
28-Feb-2011 - Tokyo, Japan-based digital imaging specialist, Fujifilm, has agreed a deal to buy US drug giant Merck and Co's BioManufacturing Network, including two biotech manufacturing plants.
28-Feb-2011 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Merck KGaA, Codexis, DSM and West.
23-Feb-2011 - Japanese drugmaker, Kyowa Hakko Kirin, has further expanded its presence in foreign markets after agreeing a deal to buy Scottish drug firm, ProStrakan.
23-Feb-2011 - Bayer has announced plans to considerably expand its pharmaceutical activities in the coming years.
23-Feb-2011 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Hemispherx Biopharma, Novartis and InVivo.
22-Feb-2011 - AstraZeneca has become the latest drug firm to invest in Russian manufacturing capcity with the announcment of plans for a $150m facility in the country’s Kaluga region.
22-Feb-2011 - GlaxoSmithKline (GSK) has confirmed that job cuts in its neurosciences group will affect less than 50 people, but half those cuts are coming from the company's US headquarters in North Carolina.
17-Feb-2011 - US drugmaker Merck & Co has not found a buyer for an R&D lab operated by its MSD-Organon division may consider closing the facility, according to a number of media reports.
16-Feb-2011 - French drugmaker Sanofi Aventis will buy Genzyme after the firms finally agree a valuation based on manufacturing performance, approvals and sales.
16-Feb-2011 - EMD Serono Inc., an affiliate of pharma giant Merck, has announced the opening of a new research centre in Massachusetts, US.
15-Feb-2011 - Shamla Pharmaceutical Industries has announced it will build a manufacturing facility in King Abdullah Economic City (KAEC), Saudi Arabia.
15-Feb-2011 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at PhRMA, BIO, Shire, Eli Lilly and DPT Laboratories.
10-Feb-2011 - The European Directorate for the Quality of Medicines & HealthCare (EQDM) has begun Phase 2 of its “track & track” anti-counterfeiting strategy and is seeking manufacturer participation.
10-Feb-2011 - GSK has unveiled plans to move its operations in Philadelphia to a purpose built facility due to be constructed at a former US Navy shipyard.
10-Feb-2011 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Stabilitech, Unilife, Genocea and Amarin.